Agilon Health
148 hedge funds and large institutions have $9.02B invested in Agilon Health in 2022 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 22 reducing their positions, and 15 closing their positions.
218% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 22
193% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 15
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
22% more funds holding
Funds holding: 121 → 148 (+27)
0.08% more ownership
Funds ownership: 3.99% → 4.06% (+0.08%)
11% less capital invested
Capital invested by funds: $10.1B → $9.02B (-$1.11B)
35% less call options, than puts
Call options by funds: $18.4M | Put options by funds: $28.4M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$91.3M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$81.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$36.4M |
| 5 |
BlackRock
New York
|
+$16.3M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$59.9M |
| 2 |
Morgan Stanley
New York
|
-$25.8M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$24.7M |
| 4 |
IM
Islet Management
New York
|
-$16.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.8M |
AGL Hedge Fund Activity: Q2 2022 in Review
148 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2022, worth a combined $9.02B — down 11% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new AGL positions and 15 closed out — a net gain of 29 holders — while 70 added to existing stakes and 22 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $91.3M. The largest seller was Capital World Investors, cutting an estimated $59.9M.
- 148 institutional investors held Agilon Health (AGL) as of Q2 2022, up from 121 in Q1 2022.
- Funds reported $9.02B of Agilon Health stock for Q2 2022, down 11% quarter-over-quarter.
- 44 funds opened new Agilon Health positions in Q2 2022 and 15 closed out, a net change of +29 holders.
- The largest Agilon Health buyer in Q2 2022 was Fidelity Investments, an estimated $91.3M added.
- The largest Agilon Health seller in Q2 2022 was Capital World Investors, an estimated $59.9M sold.
Based on aggregated 13F filings for Q2 2022.